Sales - Clinical Research Informer

Moderna shares fall amid lower sales outlook for RSV, COVID shots

Bio Pharma Dive

AUGUST 1, 2024

The biotech cited competitive pressure and “very low” expected sales in Europe for its latest guidance cut, which sent shares down by nearly 20%.

Sales

In strengthening Spravato sales, a positive sign for psychedelic drugs

Bio Pharma Dive

JULY 17, 2024

Jefferies analyst Andrew Tsai views growing sales for J&J’s depression treatment as evidence that psychedelics like it can be commercially viable.

Sales

Sales Drugs

Sanofi’s $17bn sale of Opella to US investors advances following government deal

Pharmaceutical Technology

OCTOBER 21, 2024

A stake by France-owned Bpifrance and promise of local job retention have allayed political backlash over the sale of Sanofi’s consumer health business.

Sales

GSK raises forecasts on strong vaccine, HIV drug sales

Bio Pharma Dive

MAY 1, 2024

Sales of the shingles vaccine Shingrix and the RSV shot Arexvy helped fuel quarterly revenue totals that surpassed analyst expectations, though the company warned momentum could slow in the months ahead.

Sales

Sales Vaccine Vaccination Drugs

An Innovative & Creative Problem Solver Approach to Selling in the Medical Device Space

Speaker: Steve Goldstein, Sales Leader

Are you currently in sales, or involved in a business that depends on strong sales results? What about the extremely competitive world of medical device sales? Join Steve Goldstein, Sales Success Coach, Motivational Speaker and Medical Device Sales Leader from Gold Selling LLC., Toastmasters Champion.

Sales

Sarepta reveals lower Elevidys sales, but points to ‘massive’ opportunity ahead

Bio Pharma Dive

AUGUST 8, 2024

Company executives claimed “unprecedented demand” for the Duchenne gene therapy will soon cause a sales surge, countering a dip in quarterly sales and financial projections that raised concerns among investors.

Sales

Sales Gene Therapy Gene

Jan Aushadhi Kendras report 6.7 per cent growth in sales in August

AuroBlog - Aurous Healthcare Clinical Trials blog

OCTOBER 2, 2024

per cent growth in sales of generic medicines at Maximum Retail Price (MRP) value in the month of August, as compared to the sales same month a year […]

Sales

Sales Medicine Clinical Trials Clinical Trials

Lilly hikes revenue forecast by $2B as GLP-1 drug sales climb

Bio Pharma Dive

APRIL 30, 2024

Supply continues to be tight, however, and the company anticipates further sales growth to be limited by how quickly it can bring on additional production capacity.

Sales

Sales Production Drugs

Pfizer’s strong Vyndaqel sales draw attention to rare disease drug’s patent life

Bio Pharma Dive

MAY 1, 2024

Sales of the transthyretin amyloidosis treatment widely beat Wall Street forecasts in the first quarter. The company aims to extend its patent exclusivity.

Sales

Pfizer’s Covid-19 vaccine sales forecasts upgraded with sales of $37bn in 2022

Pharmaceutical Technology

FEBRUARY 21, 2023

Pfizer and BioNTech’s Covid-19 vaccine, Comirnaty, had a phenomenal year with forecast sales of $37bn in 2022. Comirnaty is the leading prophylactic vaccine for Covid-19 and is expected to generate an additional $2.8bn in sales in 2022 compared to GlobalData’s H1 2022 forecast. Comirnaty is the first globally approved Covid-19 vaccine.

Sales

Sales Vaccine Vaccination Medicine

GSK sales of RSV vaccine stay strong, beating forecast

Bio Pharma Dive

JANUARY 31, 2024

The British drugmaker reported Arexvy sales of about $1.5 billion for 2023, higher than the range it had previously predicted for the year.

Sales

Sales Vaccine Vaccination

Novo sees Wegovy sales dip on lower price, tight supply

Bio Pharma Dive

MAY 2, 2024

First quarter sales of the in-demand obesity drug were down slightly compared to the fourth quarter last year, as the company tries to meet demand.

Sales

Sales Drugs

Eli Lilly boosts sales forecast by $3bn as diabetes and weight loss drugs propel revenue

Pharmaceutical Technology

AUGUST 9, 2024

Days after competitor Novo Nordisk posted underwhelming Wegovy sales, Eli Lilly cited “strong performance” for Zepbound and Mounjaro.

Sales

Sales Drugs

Novo Nordisk aims for market domination, boasts $1.5bn obesity sales in Q1

Pharmaceutical Technology

MAY 2, 2024

Novo Nordisk noted a 22% boost in sales owing to increased sales of GLP-1 agonists and other obesity products.

Sales

Sales Marketing Production

UniQure, with sale of plant, outsources Hemgenix manufacturing

Bio Pharma Dive

JULY 1, 2024

The gene therapy developer, which cut jobs in October, expects the sale of a Lexington, Massachusetts, facility to Genezen to lower its cash burn.

Sales

Sales Gene Therapy Manufacturing Gene

BioMarin pares Roctavian spending as it narrows sales focus

Bio Pharma Dive

AUGUST 6, 2024

The company plans to limit sales of the hemophilia gene therapy to the U.S., Italy and Germany, while ending most clinical development work.

Sales

Sales Gene Therapy Clinical Development Gene

Novo, Lilly buoyed by fast-growing GLP-1 drug sales

Bio Pharma Dive

NOVEMBER 2, 2023

The rival companies reported strong quarterly sales growth for their latest products, which could face off as weight loss treatments next year.

Sales

Sales Production Drugs

Leqembi sales inch higher; Spark’s pivot leads to layoffs

Bio Pharma Dive

JULY 12, 2024

Sales data suggest forecasts for the Alzheimer’s drug may be in reach. Elsewhere, Ipsen is licensing an ADC and Novartis is closing a San Diego site.

Sales

Sales Licensing Licensing Drugs

Novo boosts sales outlook on strong demand for obesity drug

Bio Pharma Dive

APRIL 13, 2023

The Danish drugmaker nearly doubled the 2023 forecasts for Wegovy and Ozempic in the latest indicator of the sales potential of an emerging and competitive class of weight loss drugs.

Sales

Sales Drugs

GSK partners with Chinese pharma to expand Shingrix sales

Bio Pharma Dive

OCTOBER 9, 2023

The purchase agreement with Chongqing Zhifei Biological Products is part of GSK’s plan to double sales of the shingles vaccine by 2026.

Sales

Sales Vaccine Vaccination Production

WuXi debates sale of pharma operations as BIOSECURE Act advances

Pharmaceutical Technology

OCTOBER 4, 2024

WuXi is considering the sale of some US and European operations to mitigate the impact of upcoming restrictions.

Sales

How to Leverage Omnichannel & Sales Enablement Technologies for Pharmaceutical Sales Success

Pharma Mirror

JUNE 23, 2023

In the fast-paced, highly competitive pharmaceutical industry, sales reps must adapt to new ways of engaging with customers and healthcare professionals (HCPs).

Sales

Sales Development Marketing

Merck reports rise in group net sales in fiscal 2022

Pharmaceutical Technology

MARCH 2, 2023

Merck has reported an increase in group net sales by 12.9% The growth in sales was driven by all regions and business sectors, particularly Life Science. in group sales in fiscal 2022. Additionally, due to the acquisition of Exelead, a biopharmaceutical contract development and manufacturing company, sales increased by 0.4%.

Sales

Sales Life Science Licensing Licensing

Moderna cuts sales forecasts for its COVID-19 vaccine

Bio Pharma Dive

NOVEMBER 3, 2022

The biotech dialed back its financial projections after reporting lower-than-expected sales for the shot, which currently remains the company’s only marketed product.

Sales

Sales Vaccine Vaccination Production

Pharma earnings outline drug law’s looming impact on sales, development

Bio Pharma Dive

NOVEMBER 9, 2022

While many companies are still unsure of the Inflation Reduction Act's effects, some have begun to warn investors about the likelihood of lower sales and reduced profitability.

Sales

Sales Development Drugs

Rx Machina: How AI is transforming pharma sales

Pharmaceutical Technology

JULY 31, 2023

Pharma sales have undergone a seismic transformation after Covid-19, with the adoption of artificial intelligence tools.

Sales

Bluebird bolsters balance sheet with sale of second regulatory fast pass

Bio Pharma Dive

JANUARY 6, 2023

The gene therapy developer will receive $95 million from Bristol Myers Squibb, slightly less than it got in the recent sale of another priority review voucher.

Sales

Sales Gene Therapy Gene Development

Merck reports 2% increase in worldwide sales in Q4 2022

Pharmaceutical Technology

FEBRUARY 3, 2023

Merck (MSD outside North America) has reported a 2% increase in worldwide sales to $13.83bn in the fourth quarter (Q4) of 2022 from $13.52bn in the previous year’s quarter. The company’s pharmaceutical sales recorded a 1% rise to $12.18bn compared to $12.03bn in the prior-year quarter. in the same quarter last year.

Sales

Sales Engineer Vaccine Vaccination

Bristol Myers CAR-T sales rise, despite production problems

Bio Pharma Dive

JULY 27, 2022

A manufacturing issue for Breyanzi, meanwhile, impacted sales. Demand has increased faster than Bristol Myers can make Abecma, although the company said supply is improving.

Sales

Sales Production Manufacturing

Novartis raises forecasts as top drug sales beat Wall Street estimates

Bio Pharma Dive

APRIL 23, 2024

Sales of Entresto and Cosentyx grew faster in the first quarter than analysts anticipated, helping drive the quarterly beat and raise.

Sales

Sales Drugs

J&J puts focus on cancer drugs in push to reach 2025 sales target

Bio Pharma Dive

JANUARY 24, 2023

The drugmaker reported fourth quarter revenue that fell short of forecasts, but reiterated confidence in reaching a $60 billion pharmaceutical sales goal.

Sales

Sales Drugs

Moderna looks to new COVID booster, RSV shot to curb falling sales

Bio Pharma Dive

AUGUST 3, 2023

Sales of the company’s COVID-19 vaccine plummeted 94% year over year. But executives believe newer products can help revenue rebound.

Sales

Sales Vaccine Vaccination Production

Novo Nordisk’s Wegovy sales weaken as Eli Lilly’s Zepbound exerts pressure

Pharmaceutical Technology

AUGUST 7, 2024

Shares in Novo Nordisk slid as supply bottlenecks and a more crowded weight loss treatment space depress Wegovy sales.

Sales

DoP to frame ‘Disposal Policy’ for safe removal of unused and expired drugs from household & sale premises

AuroBlog - Aurous Healthcare Clinical Trials blog

SEPTEMBER 10, 2024

In order to avoid environmental hazards due to pharmaceutical products, the Department of Pharmaceuticals (DoP) is thinking of framing a ‘Disposal Policy’ for removing the unused and date-expired drugs from the sale premises and from the households.

Sales

Sales Drugs Production Clinical Trials

US plans shift to private market sales of COVID-19 vaccines, drugs

Bio Pharma Dive

AUGUST 17, 2022

The federal government will begin the transition as early as this fall, clearing the way for drugmakers to control sales and distribution of their shots and therapeutics.

Sales

Sales Marketing Vaccine Vaccination

Novartis wins FDA approval for new heart drug, but faces uphill sales battle

Bio Pharma Dive

DECEMBER 22, 2021

Leqvio, which Novartis acquired for nearly $10 billion two years ago, arrives with high sales expectations. But uptake could be slow as insurers and doctors weigh the drug's safety and cost-effectiveness.

Sales

Sales FDA Approval Doctor Doctors

Merck sees up to $7B in coming sales of coronavirus pill

Bio Pharma Dive

OCTOBER 28, 2021

But sales could climb even higher if it works as a preventive treatment too. Executives based their projections on contracts already in place for the drug, known as molnupiravir.

Sales

Sales Drugs

Aerie’s glaucoma drug journey ends in $770M sale to Alcon

Bio Pharma Dive

AUGUST 23, 2022

The biotech successfully brought two medicines to market, but shares have lost most of their value amid sluggish sales.

Sales

Sales Medicine Drugs Marketing

Amgen's marketing efforts help boost Tepezza sales

Fierce Pharma

AUGUST 7, 2024

In the second quarter, Tepezza generated $479 million in sales for an increase of 8% year over year and 13% sequentially. It was Tepezza’s highest quarterly sales figure since Q4 of 2022. Is the thyroid eye disease (TED) treatment finally gaining momentum that is sustainable?

Sales

Sales Marketing

Physician comfort level with sales reps using AI for sales messaging is growing

Pharmaceutical Technology

AUGUST 23, 2023

Physicians with experience with using AI in their practices were more open to sales representatives using AI to personalise messaging.

Sales

Bayer reports drop in Q1 sales amidst patent litigation challenges

Pharmaceutical Technology

MAY 14, 2024

Bayer announced a fall in Q1 sales and predicted future challenges in the Xarelto market in its Q1 update.

Sales

Sales Marketing

J&J leans on cancer drug sales to maintain first quarter growth

Bio Pharma Dive

APRIL 18, 2023

Revenue topped analyst forecasts on strong market performance from the pharma’s multiple myeloma treatments, as well as the last quarter of significant COVID-19 vaccine sales.

Sales

Sales Vaccine Vaccination Drugs

Jardiance and Ofev propel Boehringer’s human pharma sales

Pharmaceutical Technology

APRIL 16, 2024

Boehringer Ingelheim announced consistent growth across its human pharma sales and R&D investments in 2023.

Sales

Bristol Myers says new drugs sales will grow more slowly

Bio Pharma Dive

OCTOBER 26, 2023

Company shares fell Thursday as the company adjusted its medium-term guidance for sales of new products like Reblozyl, Camzyos and Abecma.

Sales

Sales Production Drugs

Moderna shares fall amid lower sales outlook for RSV, COVID shots

In strengthening Spravato sales, a positive sign for psychedelic drugs

Trending Sources

Sanofi’s $17bn sale of Opella to US investors advances following government deal

GSK raises forecasts on strong vaccine, HIV drug sales

An Innovative & Creative Problem Solver Approach to Selling in the Medical Device Space

Sarepta reveals lower Elevidys sales, but points to ‘massive’ opportunity ahead

Jan Aushadhi Kendras report 6.7 per cent growth in sales in August

Lilly hikes revenue forecast by $2B as GLP-1 drug sales climb

Pfizer’s strong Vyndaqel sales draw attention to rare disease drug’s patent life

Pfizer’s Covid-19 vaccine sales forecasts upgraded with sales of $37bn in 2022

GSK sales of RSV vaccine stay strong, beating forecast

Novo sees Wegovy sales dip on lower price, tight supply

Eli Lilly boosts sales forecast by $3bn as diabetes and weight loss drugs propel revenue

Novo Nordisk aims for market domination, boasts $1.5bn obesity sales in Q1

UniQure, with sale of plant, outsources Hemgenix manufacturing

BioMarin pares Roctavian spending as it narrows sales focus

Novo, Lilly buoyed by fast-growing GLP-1 drug sales

Leqembi sales inch higher; Spark’s pivot leads to layoffs

Novo boosts sales outlook on strong demand for obesity drug

GSK partners with Chinese pharma to expand Shingrix sales

WuXi debates sale of pharma operations as BIOSECURE Act advances

How to Leverage Omnichannel & Sales Enablement Technologies for Pharmaceutical Sales Success

Merck reports rise in group net sales in fiscal 2022

Moderna cuts sales forecasts for its COVID-19 vaccine

Pharma earnings outline drug law’s looming impact on sales, development

Rx Machina: How AI is transforming pharma sales

Bluebird bolsters balance sheet with sale of second regulatory fast pass

Merck reports 2% increase in worldwide sales in Q4 2022

Bristol Myers CAR-T sales rise, despite production problems

Novartis raises forecasts as top drug sales beat Wall Street estimates

J&J puts focus on cancer drugs in push to reach 2025 sales target

Moderna looks to new COVID booster, RSV shot to curb falling sales

Novo Nordisk’s Wegovy sales weaken as Eli Lilly’s Zepbound exerts pressure

DoP to frame ‘Disposal Policy’ for safe removal of unused and expired drugs from household & sale premises

US plans shift to private market sales of COVID-19 vaccines, drugs

Novartis wins FDA approval for new heart drug, but faces uphill sales battle

Merck sees up to $7B in coming sales of coronavirus pill

Aerie’s glaucoma drug journey ends in $770M sale to Alcon

Amgen's marketing efforts help boost Tepezza sales

Physician comfort level with sales reps using AI for sales messaging is growing

Bayer reports drop in Q1 sales amidst patent litigation challenges

J&J leans on cancer drug sales to maintain first quarter growth

Jardiance and Ofev propel Boehringer’s human pharma sales

Bristol Myers says new drugs sales will grow more slowly

Stay Connected